[1]
S. U. Orhan, F. Bulut, S. Tekin, and M. Ozcan, “Fibroblast growth factor-21: Preserving cell viability in diabetic neuropathy through the AKT/PI3K cellular pathway”, Ann Med Res , vol. 31, no. 8, pp. 605–610, Aug. 2024, Accessed: Sep. 14, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4722